Cadre Holdings, Inc.

Cadre Holdings, Inc.(CDRE)の株式分析

$27.600

+0.560 (+2.03%)終値時点

Loading chart…
高値
27.600
始値
27.270
出来高加重平均価格
27.40
出来高
502.76K
時価総額
1.34B
安値
27.000
売買代金
13.78M
EV/EBITDA(TTM)
12.07

Cadre Holdings, Inc. is engaged in the manufacturing and distribution of safety products. The Company's equipment provides protection to allow users to safely perform their duties and protect those around them in hazardous or life-threatening situations. Its core products include body armor, explosive ordnance disposal equipment, duty gear and nuclear safety products. Its principal body armor product offerings include concealable, corrections and tactical armor, which provide varying levels of protection against ballistic or sharp instrument threats. It offers an engineered portfolio of critical operator survival suits, blast sensors, accessories and vehicle blast attenuation seats for bomb safety technicians, among others. Its engineered products are utilized in over 100 countries by federal, state and local law enforcement, fire and rescue professionals, explosive ordnance disposal teams, and emergency medical technicians. Its key brands include Safariland and Med-Eng, among others.

www.cadre-holdings.com

AI分析 of Cadre Holdings, Inc. (CDRE)

買い

Cadre Holdings Inc is a good buy right now due to its recent positive performance and strong analyst ratings. The stock has seen a 7.45% increase over the last five days, and analysts have set a price target of $43, suggesting a potential upside of 63.1%. Additionally, the forward P/E ratio of 18.15 indicates that the stock may be undervalued compared to its growth prospects. However, the main risk is the recent insider selling by CEO Warren B. Kanders, who sold 75,000 shares, which could signal a lack of confidence in the company's near-term performance.

バリュエーション指標

Cadre Holdings, Inc.(CDRE)の現在の予想PERは18.15で、5年平均は30.24です。

予想PER

適正
5年平均 P/E
30.24
現在のP/E
18.15
割高
46.23
割安
14.26

予想EV/EBITDA

適正
5年平均 EV/EBITDA
13.22
現在のEV/EBITDA
12.07
割高
15.05
割安
11.39

予想PSR

割安
5年平均 P/S
2.01
現在のP/S
1.43
割高
2.33
割安
1.68

Alphio AI による CDRE の価格シナリオ

シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

強

強気

強気 · 25%CDRE

$34.59

シナリオ価格

基

基本

基本 · 50%CDRE

$30.16

シナリオ価格

弱

弱気

弱気 · 25%CDRE

$29.75

シナリオ価格

CDRE を保有するクジラ

G

Greenhouse Funds LLLP

+ を保有CDRE

+4.62%

3か月リターン

イベントタイムライン

2026-08-05 (ET)

16:30:00

Company Reports Q2 Revenue of $207.1M, Exceeding Expectations

16:30:00

Cadre Raises 2026 Sales Guidance to $749-$769 Million

2026-06-02 (ET)

16:20:00

Cadre Holdings Subsidiary Safariland Wins $61 Million FBI Contract

2026-05-11 (ET)

16:30:00

Cadre Reports Q1 Revenue of $155.4M, Exceeds Expectations

16:30:00

Company Confirms FY26 Adjusted EBITDA View of $136M-$141M

ニュース

CDRE のよくある質問 — Alphio AI が回答

Cadre Holdings, Inc. is engaged in the manufacturing and distribution of safety products. The Company's equipment provides protection to allow users to safely perform their duties and protect those around them in hazardous or life-threatening situations. Its core products include body armor, explosive ordnance disposal equipment, duty gear and nuclear safety products. Its principal body armor product offerings include concealable, corrections and tactical armor, which provide varying levels of protection against ballistic or sharp instrument threats. It offers an engineered portfolio of critical operator survival suits, blast sensors, accessories and vehicle blast attenuation seats for bomb safety technicians, among others. Its engineered products are utilized in over 100 countries by federal, state and local law enforcement, fire and rescue professionals, explosive ordnance disposal teams, and emergency medical technicians. Its key brands include Safariland and Med-Eng, among others. It operates in the Industrials sector (ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUP industry).

Cadre Holdings Inc is a good buy right now due to its recent positive performance and strong analyst ratings. The stock has seen a 7.45% increase over the last five days, and analysts have set a price target of $43, suggesting a potential upside of 63.1%. Additionally, the forward P/E ratio of 18.15 indicates that the stock may be undervalued compared to its growth prospects. However, the main risk is the recent insider selling by CEO Warren B. Kanders, who sold 75,000 shares, which could signal a lack of confidence in the company's near-term performance.

コミュニティ

もっと見る ↗

投稿はまだありません

登録またはログインして議論に参加

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める